MORE THAN 35 YEARS OF EXPERIENCE

Neuraxpharm,
your CNS Specialist

Finding solutions for disorders related to the central nervous system.
Scroll to explore

Driving change

Neuraxpharm
Commitment

1 in 4 people in the world will be affected by mental or neurological disorders at some point in their lives. Roughly every family will have at least one afflicted person in the home.

The wellbeing of those suffering from these disorders is at the heart of all we do. They are the center around whom we investigate and create our solutions.

Our drive and commitment have led us into a leadership position in Europe, specializing in high-quality yet affordable pharmaceuticals for the treatment of central nervous system disorders.

We think of the doctors, the pharmacists, the caretakers and the families. We are your expert CNS specialist.

Health and wellness

Visit our section on Health and wellness and start taking care of yourself

Neuraxpharm
News

As experts in CNS disorders, we bring you the latest news, product launches and innovative initiatives we constantly undertake to always stay ahead of developments in the CNS area.

Neuraxpharm Blog

Understand more about psychiatric and neurological disorders. Our team of health care professionals and expert journalists across Europe works to consistently bring you scientifically solid, trustable information to answer your concerns.

Chronic pain

Neuropathic pain: diagnostic and therapeutic challenges

Neuropathic pain affects 7-10% of adult population and is more prevalent in elderly and in women. Find out the most common symptoms, how is diagnosed and indicated treatments.

Epilepsy

The better you and your caregivers’ understanding of your seizures, the easier it will be to manage your epilepsy. A great way to learn more about your seizures is to keep a seizure diary.

Alzheimer's

The process of human aging is complex and yet not well understood. Our body changes with age and our brain too. There are some cognitive modifications experienced by all persons, mainly slowness of the speed of processing information, less attention span, difficulties in multi-tasking and naming.

Alzheimer's

CEAFA (Spanish Alzheimer’s Confederation) estimates that around 1,200,000 people could suffer from Alzheimer’s in Spain. The figure is obtained from the prevalence of the disease in all age ranges. As for the Spanish Neurology Society (SEN), it warns of an alarming underdiagnosis in our country, stating that up to 30% of cases could be undiagnosed.